Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers

Joshi J. Alumkal, James G. Herman

    Research output: Contribution to journalArticle

    7 Scopus citations

    Abstract

    This issue of Cancer Discovery features an article that describes distinct epigenetic mechanisms that operate in TMPRSS2-ERG fusion-negative prostate cancers. This finding clarifies molecular features of these TMPRSS2-ERG fusion-negative tumors and may have implications for how to treat this prostate cancer subtype.

    Original languageEnglish (US)
    Pages (from-to)979-981
    Number of pages3
    JournalCancer discovery
    Volume2
    Issue number11
    DOIs
    StatePublished - Nov 2012

    ASJC Scopus subject areas

    • Oncology

    Fingerprint Dive into the research topics of 'Distinct epigenetic mechanisms distinguish TMPRSS2-ERG fusion-positive and -negative prostate cancers'. Together they form a unique fingerprint.

  • Cite this